Imageable microspheres for SIRT work-up

A personalized approach to SIRT

Visualizing SIRT success from the start

QuiremScout® is used to safely evaluate the distribution of intra-arterially injected microspheres prior to performing SIRT. The insights gained with QuiremScout® can be used by the treating physician to make an informed decision about the expected safety and efficacy of the SIRT procedure. Studies show that lung-shunt and intrahepatic distribution can be more accurately assessed with QuiremScout® compared to the commonly used surrogate Tech-99m-MAA.

QuiremScout® in a 73-yo female HCC-patient

QuiremScout® - Case example

A 73-yo female patient suffering from HCC received a scout dose of Holmium-166 microspheres (QuiremScout®) prior to SIRT. The distribution of the scout dose microspheres was used to evaluate the safety/efficacy profile of the SIRT treatment. Use the slider on the left to compare the scout and post-therapy SPECT/CT images. Click below to read more about this case.

QuiremScout® is indicated for patients that are eligible for SIRT treatment of liver tumors.

QuiremScout® is intended for evaluation of lung-shunt, extrahepatic deposition and intrahepatic distribution of intra-arterially injected microspheres.

QuiremScout® is contraindicated for patients that

  • are not eligible for SIRT;
  • have uncorrectable abnormal vascular anatomy that would result in significant reflux of hepatic arterial blood to the lungs, stomach, pancreas or bowel;

You can download the QuiremScout® Instructions for Use on the Product Documentation page.

Using microspheres as scout

Personalized SIRT, it starts with QuiremScout®

The effectiveness and safety of SIRT depends on numerous patient related factors, such as anatomy, tumor blood supply, tumor type and tumor staging. It is therefore essential that the expected SIRT treatment outcome is evaluated for each patient individually. QuiremScout® is used to simulate the SIRT treatment, using a safe dose of microspheres identical to those used for the therapy. The QuiremScout® scan can be used by the clinical team to make an informed and patient-specific clinical decision whether SIRT is likely to be beneficial.

Necessary cookies help make a website more usable by enabling basic functions such as page navigation and access to secure areas of the website. The website cannot function properly without these cookies.


Statistical cookies help us understand how visitors use the website by collecting and reporting data anonymously. These cookies therefore do not collect any personal data from visitors.

Cookies are small text files that can be used by websites to make user experiences more efficient. By law, we may store cookies on your device if they are strictly necessary for the use of the website. These are the functional cookies. We need your consent for all other types of cookies. These cookies are named as: preferences and statistics and you do not have to accept them. This website uses different types of cookies. Some cookies are placed by third party services that are displayed on our pages.

This website uses cookies to improve your experience. You can manage your options here.

Are you a healthcare professional?

This webpage can include promotional content regarding one or several products of Quirem Medical, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public.